Overview

Rituximab in Treating Patients With Hodgkin's Lymphoma

Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
Phase 2 trial to study the effectiveness of rituximab in treating patients who have lymphocyte-predominant Hodgkin's lymphoma.
Phase:
Phase 2
Details
Lead Sponsor:
Ranjana Advani
Collaborator:
Genentech, Inc.
Treatments:
Rituximab